Form 8-K - Current report:
SEC Accession No. 0001213900-22-060675
Filing Date
2022-09-30
Accepted
2022-09-30 16:15:22
Documents
14
Period of Report
2022-09-26
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea166544-8k_chinapharma.htm   iXBRL 8-K 27309
2 PRESS RELEASE DATED SEPTEMBER 30, 2022, ANNOUNCING THE RECEIPT OF NOTICE OF NONC ea166544ex99-1_chinapharma.htm EX-99.1 7176
3 GRAPHIC image_001.jpg GRAPHIC 5902
  Complete submission text file 0001213900-22-060675.txt   220007

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cphi-20220926.xsd EX-101.SCH 3269
5 XBRL LABEL FILE cphi-20220926_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE cphi-20220926_pre.xml EX-101.PRE 22387
8 EXTRACTED XBRL INSTANCE DOCUMENT ea166544-8k_chinapharma_htm.xml XML 3628
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 221284212
SIC: 2834 Pharmaceutical Preparations